You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Effectuez un dépistage du virus de l'hépatite B chez tous les patients cancéreux débutant un traitement systémique. Apprenez-en davantage sur le dépistage et la gestion du virus de l'hépatite B.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Que contient le nouveau formulaire de médicaments

Vous trouverez ici toutes les monographies de médicaments et de régimes nouvelles et récemment mises à jour, ainsi que les fiches de renseignements sur les patients et les documents de sécurité et de conseils.

Regimen
Published Date: 02 Sep 2025
Cancer Type:
Head and Neck, 
Squamous Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Regimen
Published Date: 02 Sep 2025
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Regimen
Published Date: 02 Sep 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Regimen
Published Date: 02 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications, Adverse effects, Administration Guidelines, and Monitoring sections

Updated
Sep 2025
Drug

Published Date: 02 Sep 2025

Revision Summary:


Drug Monograph: Added NDFP form

Updated
Sep 2025
Drug

Published Date: 21 Aug 2025

Revision Summary:
Drug Monograph: Updated Dosing, Administration and Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline.
Patient Info Sheet EN: Updated patient medication information sheet
Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:

Regimen Monograph: Added BELA maintenance information

Aug 2025
Regimen
Published Date: 20 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures, Dose Modifications, and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline

Aug 2025

Pages